Lara S van der Schoot
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 03, 2023
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.L S van der Schoot, J J Janssen, M T Bastiaens
|Dec 06, 2022
National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure.L S van der Schoot, E M Baerveldt, W A van Enst
|Jul 27, 2022
Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab.Lara S van der Schoot, Selma Atalay, Marisol E Otero
|Oct 17, 2021
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio study.Lara S van der Schoot, Juul M P A van den Reek, Lynda Grine
|Sep 01, 2021
Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide.M E van Muijen, L S van der Schoot, J M P A van den Reek
|Aug 02, 2021
Data-driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine.L S van der Schoot, J M P A van den Reek
Pageof 2
